inc headquart danver
lead provid medic devic design use
primarili use either cardiac catheter
lab cath lab intervent cardiologist
heart surgeri suit cardiovascular surgeon
patient receiv devic need
prophylact hemodynam support high-risk
angioplasti procedur experienc pre-shock
shock profound cardiogen shock
reason report
price chang estim chang analysi
invest rate
reiter o/v
increas
former price target per share follow
compani report in-lin fiscal oper result provid
acceler roll-out impella connect also posit
soft launch impella ecp fye known headwind reflect
valuat core trend demonstr improv ex
stemi-dtu trial breeth acquisit expand
compani address also drive increas impella
util longer term continu like long-term risk reward
profil lastli still anticip ipp propos
includ reduct one impella drg remain
opinion relat drg reimburs rate case
last year ultim remain favor increas devic
increas price increas former
price target establish outset crisi
revenu multipl versu former price target
base revenu multipl approxim
revis estim fine-tun former
revenu earn estim follow fiscal
releas specif revis former
million revenu earn estim
million per share respect likewis
revis former billion revenu gaap
earn estim billion per share respect
guidanc updat expect abstain provid
oper guidanc due pandem howev
compani indic monthli revenu expect improv
sequenti throughout june quarter begin stabil
septemb quarter ultim return growth
compani fy opinion aforement guidanc
increment posit consensu street view in-
keep find recent survey
import disclosur analyst certif page report access current disclosur stephen
inc cover compani client may refer
fiscal statist impella util skew favor emerg indic versu protect
pci quarter furthermor open new site result domest
hospit impella impella cp penetr impella penetr
impella rp penetr lastli fiscal oper period domest reorder rate
slightli exceed averag combin inventori held hospit impella impella cp
guidanc updat expect abstain establish oper guidanc due
pandem howev compani creat oper plan three distinct phase red yellow green
period red period fy character restrict elect case access hospit
addit compani headquart red period sale expect declin intend
support patient maintain inventori acceler impella connect reduc cost match suppress
revenu invest innov prepar next phase recoveri yellow phase
sale declin demonstr improv vs begin summer recoveri phase
govern eas restrict expect see increas util rate lastli green
phase expect return growth occur fiscal year compani
support patient hospit set provid intern extern train conjunct educ on-line
pci virtual proctor increas manufactur higher capac
abiom oper plan transit compani provid higher level
interact on-line train educ patient support smartassist impella connect pci
initi drive acceler roll-out compani smartassist impella connect offer smartassist
util impella site unit state assist impella procedur roll-out
impella connect also acceler access expand new site fiscal bring total
number site util impella connect furthermor instal requisit hardwar addit
site plan transit major compani hospit instal base on-line monitor via impella
connect
pipelin host virtual technolog pipelin overview may interim compani plan
continu launch impella unit state compani submit file impella ecp
fda plan enter market earli feasibl studi impella ecp later year addit
plan submit applic expand sheath impella fiscal subsequ
file impella cp
balanc sheet review fiscal oper period gener million oper cash flow
bring total oper cash flow gener million result exit oper
period million cash market secur debt yield net cash per share
opinion favor oper model character high cash flow gener combin cash
rich balanc sheet untap credit capac provid suffici financi latitud weather
pandem fund work capit need invest oper initi pursu strateg
opportun may aris via fund oper
valuat share current valu revenu versu compar med tech industri peer
trade like multipl view rel premium merit due larg exist address
market virtual monopoli posit top tier margin profil cash rich balanc sheet
histor project financi
remain o/v share exclud macro headwind compani demonstr si gn turn corner
revenu growth forecast acceler throughout fy plan ecp launch exit stand enhanc lt growth prospect
stemi-dtu trial breeth acquisit stand increas address market size also enhanc util
billion net cash top margin profil virtual monopoli posit circulatori support yet valu effect in-lin w/peer
fiscal result demonstr improv fundament revenu growth fh march acceler
expect revenu growth acceler sequenti throughout fiscal june restor yoy growth
breeth acquisit add ecmo portfolio potenti enhanc account penetr increas impella util
billion net cash share valu effect in-lin peer averag despit virtual monopoli model premium margin
histor project financi
potenti essenti new product pipelin experi delay push import french impella option
ipp propos releas within next day expect propos reduct minimum
fallen angel must demonstr abil effect restor top tier organ growth
end market headwind need physician educ creat near-term uncertainti
close stock price march
note million except per share data
compani document stephen inc estim
note million except per share data
compani document stephen inc estim
consolid statement incom
dollar thousand except per share data
product revenu
research develop
sell gener administr
total incom expens
fiscal period
fiscal period
incom continu oper tax
tax incom continu oper
compani report stephen inc estim
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
